{
  "id": 3722263,
  "title": "Peripheral inflammation may drive brain damage in rare neurological disorder, finds NIMHANS study",
  "url": "https://urgent.news/2026/08/27/peripheral-inflammation-may-drive-brain-damage-in-rare-neurological-3722263",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T05:00:38.000Z",
  "source": {
    "name": "The Hindu Health",
    "slug": "the-hindu-health",
    "url": "https://www.thehindu.com/news/national/karnataka/peripheral-inflammation-may-drive-brain-damage-in-rare-neurological-disorder-finds-nimhans-study/article71373744.ece"
  },
  "original_language": "en",
  "account": "A recent study conducted by researchers at NIMHANS has revealed that peripheral inflammation may be a key driver behind brain inflammation and neurodegeneration in Progressive Supranuclear Palsy (PSP), a rare neurological disorder with no current disease-modifying treatment. The findings, published in Frontiers in Immunology, offer new insights into the development of the disease and suggest the potential for identifying blood-based biomarkers for improved diagnosis and future treatment strategies. PSP, characterized by balance issues, difficulty in walking, swallowing, speaking, and eye movement impairment, is often misdiagnosed in its early stages due to overlapping symptoms with Parkinson's disease. Although previous research has linked abnormal immune responses to neurodegenerative diseases, the mechanisms through which inflammation outside the brain affects brain pathology have been unclear. Led by Professor Monojit Debnath of NIMHANS, the study aimed to explore inflammatory pathways in both the central nervous system and peripheral immune system. By examining three major pathways, including the NLRP3 inflammasome, NF-κB pathway, and Th17 pathway, the researchers found a strong link between peripheral immune system inflammation and neuroinflammation in PSP patients. Using blood and cerebrospinal fluid samples, combined with PET-MRI imaging, the team demonstrated that peripheral inflammation is closely associated with brain inflammation in PSP patients. Dr. Debnath emphasized that this is the first study to directly link peripheral inflammation to brain inflammation in Progressive Supranuclear Palsy, highlighting the importance of finding reliable blood-based biomarkers for accurate diagnosis and potential therapeutic targets. Professor Ravi Yadav, a co-author of the study, noted that understanding the relationship between systemic inflammation and brain pathology could lead to the development of simpler, more accurate diagnostic tools based on blood samples, reducing the reliance on less accurate neurological investigations. The researchers concluded that the study's findings suggest that immune processes occurring outside the brain may contribute to neuronal damage and disease progression in PSP, paving the way for further research involving larger patient groups to validate these findings and explore the potential for targeted therapies.",
  "summary": "The study demonstrated a clear association between inflammation in the peripheral immune system and neuroinflammation in patients with Progressive Supranuclear Palsy",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Hindu",
        "title": "Peripheral inflammation may drive brain damage in rare neurological disorder, finds NIMHANS study",
        "url": "https://urgent.news/2026/08/26/peripheral-inflammation-may-drive-brain-damage-in-rare-neurological",
        "published": "2026-08-26T16:13:40.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}